Haddad, Nicholas
M.D.
Biography
Nicholas Haddad, MD, FACP, FIDSA, CIC is an infectious disease specialist with more than 20 years of experience in practicing adult medicine. He received his medical degree from the American University of Beirut in Lebanon and completed an Internal Medicine residency at the Indiana University School of Medicine. Dr. Haddad furthered his training with an Infectious Disease fellowship at the Washington University School of Medicine in St. Louis, Missouri. His areas of special interest and medical expertise include complicated lung infections, fevers, communicable diseases, infections in immunocompromised individuals, and travel health (prevention, vaccination, and post-travel illnesses). Dr. Haddad has led coronavirus infection control efforts for the CMU community in Saginaw for our patient care clinics, hospitals and our workplaces. Additionally, he was appointed to the National Collegiate Athletic Association (NCAA)’s COVID-19 Medical Advisory Group alongside 15 other members in 2020. The purpose of the Medical Advisory Group is to review emerging COVID-19 research and data and provide guidance to the NCAA regarding training, practice and competition, with a primary focus on testing and mitigating infection spread. Dr. Haddad treats patients at CMU Health in Saginaw, as well as Covenant HealthCare and Ascension St. Mary’s hospitals.
More about Nicholas Haddad
Publications & Presentations
Moghnieh R, Abdallah D, Awad L, Jadayel M, Haddad N, Tamim H, Zaiter A, Awwad DC, Sinno L, El-Hassan S, Lakkis R, Khalil R, Jisr T (2020). The effect of an antibiotic stewardship program on tigecycline use in a Tertiary Care Hospital, an intervention study. Annals of clinical microbiology and antimicrobials.
Moghnieh R, Tamim H, Jadayel M, Abdallah D, Al-Kassem R, Kadiri H, Hafez H, Al-Hassan S, Ajjour L, Lakkis R, Jisr T, Samaha NL, Haddad N (2020). The effect of temporary closure and enhanced terminal disinfection using aerosolized hydrogen peroxide of an open-bay intensive care unit on the acquisition of extensively drug-resistant Acinetobacter baumannii. Antimicrobial resistance and infection control.
Khan MZ, Tahir D, Kichloo A, Haddad N, Hanan A (2020). Pyogenic Liver Abscess and Sepsis Caused by Streptococcus constellatus in the Immunocompetent Host. Cureus.
Moghnieh R, Tamim H, Abyad A, Jadayel M, Awad L, Abdallah D, Haddad N, Berberi J, Alwazir R, Taher R, Jisr T, Lakkis R, Zahran K, Ibrahim A (2020). Pre-engraftment infectious complications and patient outcomes after allogeneic hematopoietic cell transplantation: a single-center experience from Lebanon. Infection.
Khan MZ, Yousaf H, Jamil A, Shah Zaib M, Haddad N (2020). Acute Pancreatitis Associated With Hypothermia: An Uncommon Presentation. Cureus.
Haddad N, Kanj SS, Awad LS, Abdallah DI, Moghnieh RA (2019). The 2018 Lebanese Society of Infectious Diseases and Clinical Microbiology Guidelines for the use of antimicrobial therapy in complicated intra-abdominal infections in the era of antimicrobial resistance. BMC infectious diseases.
Petersen et al. (2013). Effects of Individual Physician-Level and Practice-Level Financial Incentives on Hypertension Care: A Randomized Trial Journal of the American Medical Association.
Wheat LJ, Connolly P, Haddad N, Le Monte A, Brizendine E, Hafner R (2002). Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS. Antimicrobial agents and chemotherapy.
Haddad N, Powderly WG (2001). The changing face of mycoses in patients with HIV/AIDS AIDS Read.
Credentials, Certifications & Awards
Doctor of the Year
Letters of Recognition
Special Contribution Award
Distinguished Service Award
Education
M.D., American University of Beirut, Beirut
Membership in Professional Organizations
Veterans Health Administration
Association of Professionals in Infection Control (APIC)
Lebanese Society of Infectious Disease and Clinical Microbiology (LSIDCM)
American College of Physicians
Infectious Disease Society of America (IDSA)